A few Florida beaches reopened this week despite the ongoing coronavirus pandemic, prompting one Florida lawyer, scythe in hand, to help beachgoers gain a better understanding of why that’s such a dumb idea.Read more...

Is AmerisourceBergen Corporation (NYSE:ABC) a good dividend stock? How can we tell? Dividend paying companies with...

It looks like AmerisourceBergen Corporation (NYSE:ABC) is about to go ex-dividend in the next 2 days. You can purchase...

Moody's Investors Service ("Moody's") assigned a Baa2 rating to AmerisourceBergen Corporation's ("AmerisourceBergen") new senior unsecured bonds. Moody's expects that proceeds from the company's new $500 million bond issuance will be used for general corporate purposes, including refinancing activities.

A majority of Americans don't want to go out now even if businesses do open.

AmerisourceBergen's (ABC) fiscal second-quarter earnings benefit from segmental growth.

During a segment on "Good Morning America," ABC News reporter Will Reeve accidentally revealed he was wearing shorts instead of pants for his moment on air.

Coty shares sink as revenue declined due to pandemic Continue reading...

The day has finally arrived. This afternoon, NASA astronauts Robert Behnken and Douglas Hurley are scheduled to launch aboard a SpaceX Crew Dragon and fly to the International Space Station. You can watch this historic launch live right here.Read more...

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 5.26% and 3.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018. The offering is expected to close on May 19, 2020, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering to redeem all of its 3.500% Senior Notes due November 15, 2021 and for general corporate purposes.

Good morning, and thank you all for joining us for this conference call to discuss AmerisourceBergen's Fiscal 2020 Second Quarter results. On today's call, we will be discussing non-GAAP financial measures.

Medical Product companies have partially mitigated the impact of the pandemic with the massive adoption of COVID-19 related healthcare-support products and services.

Final season picks up where S6's cliffhanger finale left off.

When it comes to the coronavirus, South Australia ought to now be considered among the safest places in the world. That was the message from one of country's leading public health officials this week, as much of Australia began the slow process of easing rest…

It’s almost June, which means it’s time to start building your list of new things to watch once the beginning of the month rolls around and your favorite streaming services experience an influx of content.Read more...

ABC News reporter Will Reeve gave a report on the future of pharmacies from his home on Tuesday morning, as so many TV journalists are being forced to do during the coronavirus pandemic. And Reeve was truly living the dream, based on photos that are now going…

Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. The market performance numbers and the statistics in the tables in this story are as of May 20.

To combat shortages due to the coronavirus pandemic, the company ABC Displays has designed a cardboard hospital bed that can transform into a coffin. CNN's Stefano Pozzebon reports.

The elaphrosaur roamed Australia 110 million years ago and was related to the Tyrannosaurus Rex.

Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.

Walgreens owns about 27% of AmerisourceBergen and is its biggest customer. The two companies have explored various possibilities for combining operations in recent years, including a sale of AmerisourceBergen to Walgreens, on the theory that their drug distribution businesses would be better positioned to withstand competitive price pressures through even bigger scale. The coronavirus pandemic has weighed on Walgreens' retail business since then, however.

The COVID-19 pandemic has forced a lot of otherwise traditional industries to become creative and flexible in ways that might have seemed entirely out of the realm of possibility only a few months ago. With most of the county at home, social distancing, a num…

Tonight graduating seniors will have the opportunity to attend a commencement ceremony with speakers including Barack Obama and LeBron James.Read more...

AmerisourceBergen's (ABC) fiscal second-quarter results likely to reflect solid performance at Pharmaceutical Distribution.

When working from home it's extremely tempting to wear comfortable clothes 24/7. Unlike that stiff Los Angeles Times op-ed, we are pro-sweats and pajamas all day, but one Good Morning America reporter's unfortunate pants-less video chat should serve as a caut…

Q2 2020 AmerisourceBergen Corp Earnings Call

AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018.

President Trump's announcement on Tuesday that he planned to wind down the administration's coronavirus task force earned him an immediate and entirely justifiable backlash, including a blast from Stephen Colbert on the Late Show. In response to millions of p…

This weekend Westworld will wrap up another mind-bending season of full of AI and robot mayhem, but the sci-fi show I’m looking forward to is on Amazon Prime. Upload comes from The Office (US) and Parks & Recreation creator Greg Daniels, telling the story of …

The Covid-19 downturn may be an opportunity for the three big U.S. drug distributors, UBS analyst Kevin Caliende says.

AmerisourceBergen Corp. reported Thursday fiscal second-quarter profit and revenue that rose above expectations, as the pharmaceutical distribution business got a boost from the COVID-19 pandemic, but the company lowered its full-year outlook. The drug products company also announced a new $500 million stock repurchase program and declared a regular quarterly dividend of 42 cents a share. Net income rose to $960.3 million, or $4.64 a share, from $27.1 million, or 13 cents a share, in the year-ago period, due primarily to tax benefits. Excluding non-recurring items, adjusted earnings per share rose 13.7% to $2.40, above the FactSet consensus of $2.27. Revenue grew 9.5% to $47.42 billion, above the FactSet consensus of $45.94 billion, as pharmaceutical distribution services revenue rose 9.3% to $45.6 billion to beat expectations of $44.44 billion. For 2020, the company cut its guidance ranges for adjusted EPS to $7.35 to 7.65 from $7.55 to $7.80 and for revenue growth to the low- to mid-single digit percentage range from the mid-to high-single digit range. The FactSet consensus for 2020 revenue of $188.8 billion implies 5.1% growth. The stock, which was still inactive in premarket trading, has gained 0.6% year to date while the S&P 500 has lost 11.8%.

AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization approach for QINLOCK which was approved by the U.S. Food and Drug Administration (FDA) on Friday, May 15, 2020. QINLOCK is an orally administered kinase switch control inhibitor approved for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 second quarter ended March 31, 2020, revenue increased 9.5 percent to $47.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $4.64 for the March quarter of fiscal 2020, compared to $0.13 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 13.7 percent to $2.40 in the fiscal second quarter.

As complaints about dire shortages of protective gear for medical workers on the frontlines of the Covid-19 crisis began to stream in, President Donald Trump was quick to point the finger of blame at his predecessor, Barack Obama.

Incredible video taken last night in Australia shows what was likely the late-stage of a Russian rocket burning up on re-entry, in a light show that was seen across the southeast portions of the country.Read more...

Here's the thing about being a true crime junkie: Despite the endless sea of new podcasts being released on a weekly and monthly basis, it's never enough. You've probably already exhausted the many lists recommending the best true crime podcasts of all time. …

The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus. The U.S. Food and Drug Administration on Friday gave emergency use authorization to Gilead Sciences Inc's remdesivir for patients with severe COVID-19 - the disease caused by the coronavirus - clearing the way for broader use in more hospitals around the United States. The federal government began distributing the drug this week.

President Donald Trump on Wednesday called footage from the Pentagon showing "unidentified aerial phenomena" a "hell of a video" and told Reuters he wonders "if it's real."

If you don't take social distancing seriously, you might run into the Grim Reaper.  In more ways than one. Lawyer Daniel Uhlfelder went viral last weekend after lurking around Florida beaches dressed as death himself in protest of beachgoers enjoying the sun …